Our Products
We offer a complete product range of Menveo Intramuscular Injection and Nactivated Influenza Vaccine Injection
Menveo is a meningococcal (groups A, C, Y, and W-135) conjugate vaccine used to protect against invasive meningococcal disease caused by Neisseria meningitidis. It is indicated for active immunization in individuals aged 2 months and older to prevent meningococcal infections, which can lead to life-threatening conditions like meningitis and septicemia. The vaccine stimulates the immune system to produce antibodies against the bacteria, reducing the risk of severe infection. Menveo is administered via intramuscular injection and is especially recommended for individuals at high risk, including travelers to endemic areas, military personnel, and those with certain medical conditions
The Inactivated Influenza Vaccine (IIV) is a killed-virus vaccine used to protect against seasonal influenza. It stimulates the immune system to produce antibodies against the influenza virus without causing infection. IIV is indicated for the prevention of influenza in individuals **6 months and older**, including high-risk groups such as the elderly, pregnant women, and individuals with chronic medical conditions. It is administered annually via intramuscular injection to provide protection against circulating influenza virus strains